News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cochlear.
RELATED STOCKHEAD STORIES
News
Closing Bell: ASX resumes rally on Powell’s remarks; goldies in focus, copper hits 12-month high
News
ASX Large Caps: Property stocks smashed after Lendlease-led rout, a2 Milk soars on solid guidance
News
Closing Bell: Blood plasma giant CSL bleeds out in front of entire ASX on Monday
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up as Cochlear upgrades earnings guidance
News
Closing Bell: Markets up almost 0.1pc on Friday as the cows take control
News
ASX Large Caps: Liontown, Boral jump, Cochlear hits record high, but uranium stocks tumble
News
ASX Large Caps: ASX gains more ground as AGL reports massive quarter, News Corp surprises
Health & Biotech
ASX Health Stocks: Cochlear upgrades guidance, Chimeric up 12pc after commencing Phase 1B trial on leukaemia
News
Closing Bell: Interest rates the only thing steady about local markets on Tuesday
News
ASX Large Caps: ASX pulls back more, RBA leaves rates alone; Nick Scali up 16pc on H1 profit beat
News
ASX Large Caps: Tech stocks power ASX higher ahead of tonight’s CPI, but Aussie business confidence slumps
News
ASX Large Caps: ASX climbs again as IRESS jumps 16pc, Cettire down 10pc as big shareholder dumps stock
Experts
Life of Brian: Weighting for opportunity
News
ASX Large Caps: ASX higher despite rates-sensitive stocks tumbling after RBA report, Bapcor down 12pc
Health & Biotech
ScoPo’s Powerplays: Who remembers that time they died? Oh, and Ramsay Healthcare cops credit downgrade
Experts
Around the ASX in 7 companies at the Pinnacle of their game
News